The pharmaceutical industry had to adapt quickly to the pandemic if it was to continue to supply important medicines, while also racing to develop vaccines and treatments. Supply chains have come under intense pressure, and companies of all kinds have had to adapt to this “new normal” to avoid delays. During this Q&A, Catalent discusses the challenges they faced and solutions they implemented to overcome the daunting challenges during the pandemic.